Bullfrog AI (BFRG) Stock Price, News & Analysis

Company Overview

BullFrog AI Holdings, Inc. is a biotechnology-focused artificial intelligence company that develops machine-learning tools for the healthcare and life sciences industries. The company’s work is centered on using artificial intelligence to analyze complex biomedical data and support more efficient approaches to drug development and precision medicine.

Its primary technology platform, bfLEAP, is designed to process and interpret large datasets, including genomic and clinical information. BullFrog AI offers data analysis and related services intended to help pharmaceutical companies, biotechnology firms, researchers and other healthcare organizations identify patterns, potential biomarkers, patient subgroups and other insights that may inform therapeutic development.

The company has positioned its business around applying artificial intelligence to areas such as oncology, neurological disorders and other complex diseases. BullFrog AI is headquartered in the United States and primarily operates in the healthcare and biotechnology markets, working with organizations that need advanced analytics for biomedical research and drug-development programs.

Key Stats

• Today's Range: $0.52 to $0.57
• 50-Day Range: $0.43 to $0.95
• 52-Week Range: $0.43 to $1.96
• Volume: 34,370 shs
• Average Volume: 5.03 million shs
• Market Capitalization: $9.81 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Reduce

Bullfrog AI Stock Analysis - MarketRank™

Bullfrog AI scored higher than 34% of companies evaluated by MarketBeat, and ranked 745th out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Reduce

Consensus Rating

Bullfrog AI has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.

Amount of Analyst Coverage

Bullfrog AI has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Bullfrog AI are expected to grow in the coming year, from ($0.37) to ($0.17) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Bullfrog AI is -1.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Bullfrog AI is -1.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Bullfrog AI has a P/B Ratio of 2.90. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.76% of the float of Bullfrog AI has been sold short.

Short Interest Ratio / Days to Cover

Bullfrog AI has a short interest ratio ("days to cover") of 4.31.

Change versus previous month

Short interest in Bullfrog AI has recently decreased by 25.49%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Bullfrog AI does not currently pay a dividend.

Dividend Growth

Bullfrog AI does not have a long track record of dividend growth.

News and Social Media

• Score: 2.4 / 5
• News Sentiment: N/A

News Sentiment

Bullfrog AI has a news sentiment score of 0.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Bullfrog AI this week, compared to 2 articles on an average week.

Search Interest

Only 1 people have searched for BFRG on MarketBeat in the last 30 days. This is a decrease of -86% compared to the previous 30 days.

Company Ownership

• Score: 4.1 / 5
• Insider Trading: Acquiring Shares

Cluster Insider Buying

2 insiders have purchased shares of Bullfrog AI in the last three months. Multiple insiders buying is a strong bullish signal.

Net Insider Buying

Over the last three months, insiders have purchased a net $71,500.00 in company stock, which represents 0.6999% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, Bullfrog AI insiders have bought more of their company's stock than they have sold. Specifically, they have bought $71,500.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

14.70% of the stock of Bullfrog AI is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

0.96% of the stock of Bullfrog AI is held by institutions.

Company Calendar

• Last Earnings: 8/14/2026
• Today: 11/13/2026
• Next Earnings (Estimated): 11/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Life Sciences Tools & Services
• Sub-Industry: Life Sciences Tools & Services
• Current Symbol: NASDAQ:BFRG
• CIK: 1829247
• Web: www.bullfrogai.com
• Phone: (301) 367-2055
• Fax: N/A
• Employees: 17
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.46)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$6.50 million
• Net Margins: N/A
• Pretax Margin: -2,012.08%
• Return on Equity: -150.36%
• Return on Assets: -127.98%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 10.57
• Quick Ratio: 10.57

Sales & Book Value

• Annual Sales: $120 thousand
• Price / Sales: 81.89
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.19 per share
• Price / Book: 2.79

Miscellaneous

• Outstanding Shares: 18,540,000
• Free Float: 15,816,000
• Market Cap: $9.83 million
• Optionable: Not Optionable
• Beta: -2.60